At NASMAC, we are addressing the growing challenge of non-communicable chronic diseases (NCDs). With a clear focus on diseases such as cancer, respiratory conditions, and chronic conditions like diabetes and cardiovascular diseases, we provide accessible, affordable, and effective treatments that are made to meet the needs of patients and healthcare institutions across Saudi Arabia.
Our R&D efforts are driven by a commitment to close the gaps left by traditional pharmaceutical models, with a focus on non-communicable diseases that continue to shape the Kingdom’s healthcare landscape. From neuropsychiatric disorders and diabetes to cardiovascular diseases, cancer, obesity, and asthma/COPD, our research prioritizes conditions with high prevalence and profound social impact.
Nasmac offers treatments for chronic respiratory conditions, including asthma and COPD. Our products are designed to improve long-term management and help patients lead healthier lives with reliable and easy-to-use therapies.
Respiratory Care Solutions
We focus on improving the lives of patients living with chronic endocrine conditions, particularly diabetes. Our mission is to provide accessible, affordable, and patient-centered solutions that empower individuals to manage their condition more effectively and improve their overall quality of life.
Endocrinology
We are committed to improve the care for neuropsychiatric and neurological disorders. Our CNS treatments combine scientific innovation with local accessibility, supporting healthcare professionals in providing patients with stability, functionality, and a better quality of life.
Central Nervous System Therapies
We tackle the rising burden of cardiovascular diseases in Saudi Arabia with effective, affordable, and accessible therapies. Our cardiovascular portfolio focuses on the prevention and management of hypertension and dyslipidemia (cholesterol and lipid profile disorders) for a better long term heart health, and enhanced quality of life.
Cardiovascular
At NASMAC, affordability isn’t just about lower prices, it’s about treating healthcare as a basic right. Our therapies are designed as practical lifelines for individuals and families, combining fair pricing with uncompromising quality. Macleods as a fully integrated pharmaceutical from API manufacturing to finished formulations with an FDA approved Bioequivalence Center this ensures that every product meets the highest international standards while maintaining accessibility for local market.
Localization stands at the core of our mission. In a world of global pharmaceutical solutions, NASMAC stands out by choosing to not just operate in Saudi Arabia, but to become an integral part of its local healthcare ecosystem. The goal isn’t just to provide high-quality medicines but to empower Saudi Arabia to meet its healthcare needs through homegrown solutions. This commitment to self-sufficiency doesn’t just mean manufacturing locally, it means ensuring that the knowledge, technology, and expertise required for this transition are passed on to local teams, creating a culture of innovation.
Our focus is on providing oral anticancer treatments that are effective, convenient, and support better adherence to therapy. These therapies aim to improve the overall treatment experience for cancer patients in Saudi Arabia.
Oral Anticancer Therapies